cilostazol has been researched along with Blue Toe Syndrome in 1 studies
Blue Toe Syndrome: A condition that is caused by recurring atheroembolism in the lower extremities. It is characterized by cyanotic discoloration of the toes, usually the first, fourth, and fifth toes. Discoloration may extend to the lateral aspect of the foot. Despite the gangrene-like appearance, blue toes may respond to conservative therapy without amputation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Funabiki, K | 1 |
| Masuoka, H | 1 |
| Shimizu, H | 1 |
| Emi, Y | 1 |
| Mori, T | 1 |
| Ito, M | 1 |
| Nakano, T | 1 |
1 review available for cilostazol and Blue Toe Syndrome
| Article | Year |
|---|---|
Cholesterol crystal embolization (CCE) after cardiac catheterization: a case report and a review of 36 cases in the Japanese literature.
Topics: Aged; Blue Toe Syndrome; Cardiac Catheterization; Cholecystitis; Cilostazol; Coronary Angiography; C | 2003 |